Loading...
Thumbnail Image
Publication

Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonists

Throup, Adam E.
Zraikat, Manar Saleh Ali
Gordon, Andrew
Jafarinejad Soumehsaraei, S.
Haase, K.D.
Patterson, Laurence H.
Cooper, Patricia A.
Hanlon, K.
... show 2 more
Publication Date
2024-09
End of Embargo
Supervisor
Rights
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2024-08-24
Institution
Department
Awarded
Embargo end date
Abstract
The integrin family of cell surface extracellular matrix binding proteins are key to several physiological processes involved in tissue development, as well as cancer proliferation and dissemination. They are therefore attractive targets for drug discovery with cancer and non-cancer applications. We have developed a new integrin antagonist chemotype incorporating a functionalised cyclobutane ring as the central scaffold in an arginine–glycine–aspartic acid mimetic structure. Here, we report the synthesis of cyclobutanecarboxylic acids and cyclobutylamines with tetrahydronaphthyridine and aminopyridine arginine mimetic sidechains and masked carboxylic acid aspartic acid mimetic sidechains of varying length. Effective αvβ3 antagonists and new aspartic acid mimetics were identified in cell-based adhesion and invasion assays. A lead compound selected based on in vitro activity (IC50 < 1 μM), stability (t1/2 > 80 minutes) and synthetic tractability was well-tolerated in vivo. These results show the promise of this synthetic approach for developing αvβ3 antagonists and provide a firm foundation to progress into advanced preclinical evaluation prior to progression towards the clinic. Additionally, they highlight the use of functionalised cyclobutanes as metabolically stable core structures and a straightforward and robust method for their synthesis. This important contribution to the medicinal chemists' toolbox paves the way for increased use of cyclobutanes in drug discovery.
Version
Published version
Citation
Throup A, Zraikat MS, Gordon A et al (2024) Sidechain structure–activity relationships of cyclobutane-based small molecule αvβ3 antagonists. RSC Medicinal Chemistry. 15(10): 3616-3624.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article
Qualification name
Notes